Related Experiment Videos
[Multiple organ failure. Mechanisms, clinical manifestations and treatment strategies]
1Klinik für Anaesthesiologie und Intensivmedizin, Universität des Saarlandes, Kirrberger Strasse, Gebäude 57, 66421 Homburg/Saar. aimbau@uniklinik-saarland.de
Abstract:
Multiple organ failure (MOV) still represents the leading medical and economical problem in the care of the critically ill surgical patient. Although the incidence of MOF has tended to decrease over the last several years reflecting improved surgical and supportive therapy in the ICU, prognosis still remains serious when MOF develops. MOF seems to reflect a dysregulation of host-defence systems, such as innate immune, coagulation and complement systems, which are likely to reflect a more general dysregulation of cellular and subcellular functions, such as signal transduction and stress gene expression. Besides complexity and redundancy of the mediator systems involved, their beneficial local reparative as opposed to detrimental systemic effects may have contributed to the disappointing results of anti-mediator strategies in the treatment of MOF and sepsis. Although treatment of the underlying disease remains the cornerstone of the care of the critically ill patient to prevent MOF, recent results indicating a decreased mortality in severely septic patients receiving activated protein C as a supportive treatment suggest that modulation of the mediator cascades of sepsis and MOF remains a generally promising therapeutic strategy.
Insights
Multiple organ failure (MOF) in critically ill patients remains a serious challenge. Modulating mediator cascades in sepsis and MOF shows promise for improving outcomes.
Area of Science:
- Critical care medicine
- Surgical patient management
- Immunology and inflammation
Context:
- Multiple organ failure (MOF) remains a primary challenge in critically ill surgical patients, despite advances in ICU care.
- The prognosis for MOF is serious, highlighting the need for improved therapeutic strategies.
- MOF involves complex dysregulation of host-defense systems, including innate immunity, coagulation, and complement pathways.
Purpose:
- To explore the underlying mechanisms of MOF, focusing on the dysregulation of host-defense systems.
- To discuss the challenges and limitations of anti-mediator strategies in treating MOF and sepsis.
- To evaluate the potential of modulating mediator cascades as a therapeutic approach for MOF and sepsis.
Summary:
- MOF is characterized by dysregulated innate immune, coagulation, and complement systems, alongside cellular and subcellular functional impairments.
- The complex and redundant nature of mediator systems, with both local reparative and systemic detrimental effects, complicates treatment.
- While treating the underlying disease is crucial, supportive therapies like activated protein C suggest that modulating mediator cascades is a promising strategy.
Impact:
- Understanding MOF pathogenesis can lead to more targeted and effective treatments.
- Identifying key mediator pathways offers opportunities for novel therapeutic interventions.
- Improved management of MOF and sepsis can reduce mortality and economic burden in critical care settings.